{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T23:44:11Z","timestamp":1790811851562,"version":"4.1.0"},"reference-count":28,"publisher":"American Society of Hematology","issue":"16","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2018,8,28]]},"abstract":"<jats:title>Key Points<\/jats:title>\n                  <jats:p>CM-TMA is a unique subset of patient with LN. CM-TMA in LN is responsive to complement inhibition with eculizumab.<\/jats:p>","DOI":"10.1182\/bloodadvances.2018019596","type":"journal-article","created":{"date-parts":[[2018,9,14]],"date-time":"2018-09-14T16:46:43Z","timestamp":1536943603000},"page":"2090-2094","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":102,"title":["Complement-mediated thrombotic microangiopathy associated with lupus nephritis"],"prefix":"10.1182","volume":"2","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8510-0523","authenticated-orcid":false,"given":"Mi Hee","family":"Park","sequence":"first","affiliation":[{"name":"Department of Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas","family":"Caselman","sequence":"additional","affiliation":[{"name":"Department of Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott","family":"Ulmer","sequence":"additional","affiliation":[{"name":"Hematology\/Oncology, South Texas Accelerated Research and Therapeutics (START) Center for Cancer Care, San Antonio, TX; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8906-1552","authenticated-orcid":false,"given":"Ilene Ceil","family":"Weitz","sequence":"additional","affiliation":[{"name":"Department of Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA;"},{"name":"Jane Anne Nohl Division of Hematology, Keck School of Medicine, University of Southern California, Los Angeles, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2018,8,21]]},"reference":[{"issue":"7","key":"2019111616470318500_B1","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1056\/NEJMra1312353","article-title":"Syndromes of thrombotic microangiopathy","volume":"371","author":"George","year":"2014","journal-title":"N Engl J Med"},{"issue":"4","key":"2019111616470318500_B2","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1111\/j.1365-2141.2012.09032.x","article-title":"The use of ADAMTS13 activity, platelet count, and serum creatinine to differentiate acquired thrombotic thrombocytopenic purpura and other thrombotic microangiopathies","volume":"157","author":"Cataland","year":"2012","journal-title":"Br J Haematol"},{"issue":"5","key":"2019111616470318500_B3","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1002\/ajh.23960","article-title":"Drug-induced thrombotic microangiopathy: experience of the Oklahoma Registry and the BloodCenter of Wisconsin","volume":"90","author":"Reese","year":"2015","journal-title":"Am J Hematol"},{"key":"2019111616470318500_B4","article-title":"Effective treatment of chemotherapy induced atypical haemolytic uraemic syndrome: a case series of 7 treated patients [published online ahead of print 31 August 2017]","author":"Weitz","journal-title":"Br J Haematol"},{"issue":"4","key":"2019111616470318500_B5","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1038\/ki.2012.409","article-title":"Inclusion of renal vascular lesions in the 2003 ISN\/RPS system for classifying lupus nephritis improves renal outcome predictions","volume":"83","author":"Wu","year":"2013","journal-title":"Kidney Int"},{"issue":"8","key":"2019111616470318500_B6","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1038\/nrneph.2017.85","article-title":"Redefining lupus nephritis: clinical implications of pathophysiologic subtypes","volume":"13","author":"Yu","year":"2017","journal-title":"Nat Rev Nephrol"},{"issue":"9","key":"2019111616470318500_B7","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1002\/art.1780400928","article-title":"Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus","volume":"40","author":"Hochberg","year":"1997","journal-title":"Arthritis Rheum"},{"issue":"6","key":"2019111616470318500_B8","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1002\/acr.21664","article-title":"American College of Rheumatology guidelines for screening, treatment, and management of lupus nephritis","volume":"64","author":"Hahn","year":"2012","journal-title":"Arthritis Care Res"},{"issue":"23","key":"2019111616470318500_B9","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1056\/NEJMoa1208981","article-title":"Terminal complement inhibitor eculizumab in atypical hemolytic-uremic syndrome","volume":"368","author":"Legendre","year":"2013","journal-title":"N Engl J Med"},{"issue":"1","key":"2019111616470318500_B10","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1053\/j.ajkd.2014.07.031","article-title":"Thrombotic microangiopathy in systemic lupus erythematosus: efficacy of eculizumab","volume":"65","author":"El-Husseini","year":"2015","journal-title":"Am J Kidney Dis"},{"issue":"7","key":"2019111616470318500_B11","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1111\/j.1600-6143.2010.03156.x","article-title":"Thrombotic microangiopathy after kidney transplantation","volume":"10","author":"Noris","year":"2010","journal-title":"Am J Transplant"},{"issue":"8","key":"2019111616470318500_B12","doi-asserted-by":"crossref","first-page":"2460","DOI":"10.1002\/art.23662","article-title":"Potential for glomerular C4d as an indicator of thrombotic microangiopathy in lupus nephritis","volume":"58","author":"Cohen","year":"2008","journal-title":"Arthritis Rheum"},{"key":"2019111616470318500_B13","article-title":"Membrane attack complex (mac) deposition in lupus nephritis is associated with hypertension and poor clinical response to treatment [published online ahead of print 6 January 2018]","author":"Wang","journal-title":"Semin Arthritis Rheum"},{"issue":"12","key":"2019111616470318500_B14","doi-asserted-by":"crossref","first-page":"2269","DOI":"10.1093\/rheumatology\/kes218","article-title":"Serum complement factor H is associated with clinical and pathological activities of patients with lupus nephritis","volume":"51","author":"Wang","year":"2012","journal-title":"Rheumatology"},{"issue":"12","key":"2019111616470318500_B15","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1177\/0961203316642307","article-title":"The dysfunctions of complement factor H in lupus nephritis","volume":"25","author":"Wang","year":"2016","journal-title":"Lupus"},{"issue":"1","key":"2019111616470318500_B16","doi-asserted-by":"crossref","first-page":"R12","DOI":"10.1186\/ar4142","article-title":"The spectrum of renal thrombotic microangiopathy in lupus nephritis","volume":"15","author":"Song","year":"2013","journal-title":"Arthritis Res Ther"},{"issue":"3","key":"2019111616470318500_B17","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1097\/01.mnh.0000444812.65002.cb","article-title":"Diverse vascular lesions in systemic lupus erythematosus and clinical implications","volume":"23","author":"Tan","year":"2014","journal-title":"Curr Opin Nephrol Hypertens"},{"issue":"3","key":"2019111616470318500_B18","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.amjms.2017.01.005","article-title":"Complement alternative pathway\u2019s activation in patients with lupus nephritis","volume":"353","author":"Song","year":"2017","journal-title":"Am J Med Sci"},{"issue":"12","key":"2019111616470318500_B19","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1177\/0961203317702254","article-title":"Genetic variants in FH are associated with renal histopathologic subtypes of lupus nephritis: a large cohort study from China","volume":"26","author":"Tan","year":"2017","journal-title":"Lupus"},{"issue":"1","key":"2019111616470318500_B20","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1093\/bmb\/ldl004","article-title":"Atypical haemolytic uraemic syndrome","volume":"77-78","author":"Kavanagh","year":"2006","journal-title":"Br Med Bull"},{"issue":"12","key":"2019111616470318500_B21","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1182\/blood-2013-05-501445","article-title":"Abnormalities in the alternative pathway of complement in children with hematopoietic stem cell transplant-associated thrombotic microangiopathy","volume":"122","author":"Jodele","year":"2013","journal-title":"Blood"},{"issue":"8","key":"2019111616470318500_B22","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1182\/blood-2015-08-663435","article-title":"The genetic fingerprint of susceptibility for transplant-associated thrombotic microangiopathy","volume":"127","author":"Jodele","year":"2016","journal-title":"Blood"},{"issue":"9","key":"2019111616470318500_B23","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1111\/jth.12639","article-title":"Tailored eculizumab regimen for patients with atypical hemolytic uremic syndrome: requirement for comprehensive complement analysis","volume":"12","author":"Wehling","year":"2014","journal-title":"J Thromb Haemost"},{"issue":"2","key":"2019111616470318500_B24","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1111\/cei.12890","article-title":"Monitoring of complement activation biomarkers and eculizumab in complement-mediated renal disorders","volume":"187","author":"Wehling","year":"2017","journal-title":"Clin Exp Immunol"},{"issue":"1","key":"2019111616470318500_B25","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1177\/0961203313512391","article-title":"Noninflammatory necrotizing vasculopathy in lupus nephritis: a single-center experience","volume":"23","author":"Chu","year":"2014","journal-title":"Lupus"},{"issue":"1","key":"2019111616470318500_B26","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s00467-014-2944-y","article-title":"Dramatic effects of eculizumab in a child with diffuse proliferative lupus nephritis resistant to conventional therapy","volume":"30","author":"Coppo","year":"2015","journal-title":"Pediatr Nephrol"},{"issue":"8","key":"2019111616470318500_B27","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1056\/NEJMc1309449","article-title":"C4 dense-deposit disease","volume":"370","author":"Sethi","year":"2014","journal-title":"N Engl J Med"},{"issue":"12","key":"2019111616470318500_B28","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1056\/NEJMra1108178","article-title":"Membranoproliferative glomerulonephritis--a new look at an old entity","volume":"366","author":"Sethi","year":"2012","journal-title":"N Engl J Med"}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/bloodadvances\/article-pdf\/2\/16\/2090\/881494\/advances019596.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/bloodadvances\/article-pdf\/2\/16\/2090\/881494\/advances019596.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,16]],"date-time":"2019-11-16T16:47:15Z","timestamp":1573922835000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/2\/16\/2090\/15916\/Complementmediated-thrombotic-microangiopathy"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,21]]},"references-count":28,"journal-issue":{"issue":"16","published-print":{"date-parts":[[2018,8,28]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2018019596","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,8,21]]}}}